-
OPTIMAL USE OF LIPID-LOWERING THERAPY AFTER ACUTE CORONARY SYNDROMES: A Position Paper endorsed by the International Lipid Expert Panel (ILEP)M Banach, PE Penson, ACS EuroPath Central & South European Countries Project et al. -
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionTardif JC, Kouz S, Waters DD et al.
-
Intravenous Statin Administration During Myocardial Infarction Compared With Oral Post-Infarct AdministrationG Mendieta, S Ben-Aicha, M Gutiérrez et al.
-
Prevalence of Coronary Vasospasm Using Coronary Reactivity Testing in Patients With Spontaneous Coronary Artery DissectionSolaru KW, Heupler F, Kim ESH et al.
-
Post-Discharge Bleeding and Mortality Following Acute Coronary Syndromes With or Without PCIG Marquis-Gravel, F Dalgaard, AD Jones et al.
-
Phosphoproteomic Analysis of Neonatal Regenerative Myocardium Revealed Important Roles of CHK1 via Activating mTORC1/P70S6K PathwayY Fan, XJ Guo, LS Wang et al.
-
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery diseaseM Bossard, P Gao, W Boden et al.
-
Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014Szummer K, Wallentin L, Lindhagen L et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
